Published in Osteoporos Int on May 03, 2005
Osteoporosis imaging: state of the art and advanced imaging. Radiology (2012) 1.58
The prevalence of vertebral fracture amongst patients presenting with non-vertebral fractures. Osteoporos Int (2006) 1.22
Radiation exposure in X-ray-based imaging techniques used in osteoporosis. Eur Radiol (2010) 1.22
Relation between obesity and bone mineral density and vertebral fractures in Korean postmenopausal women. Yonsei Med J (2010) 1.11
Osteoporosis Canada 2010 guidelines for the assessment of fracture risk. Can Assoc Radiol J (2011) 1.11
Mild prevalent and incident vertebral fractures are risk factors for new fractures. Osteoporos Int (2007) 1.08
Locations of bone tissue at high risk of initial failure during compressive loading of the human vertebral body. Bone (2007) 1.06
Health-related quality of life after vertebral or hip fracture: a seven-year follow-up study. BMC Musculoskelet Disord (2009) 1.05
Height loss, vertebral fractures, and the misclassification of osteoporosis. Bone (2010) 1.04
Influence of baseline deformity definition on subsequent vertebral fracture risk in postmenopausal women. Osteoporos Int (2006) 1.02
Vertebral fracture assessment: impact of instrument and reader. Osteoporos Int (2009) 0.98
Mechanisms of initial endplate failure in the human vertebral body. J Biomech (2010) 0.94
Review of radiological scoring methods of osteoporotic vertebral fractures for clinical and research settings. Eur Radiol (2012) 0.93
Vertebral fracture assessment by DXA is inferior to X-ray in clinical severe osteoporosis. Osteoporos Int (2016) 0.92
Vertebral fractures and the misclassification of osteoporosis in men with prostate cancer. J Clin Densitom (2011) 0.92
Excess body fat is associated with higher risk of vertebral deformities in older women but not in men: a cross-sectional study. Osteoporos Int (2011) 0.90
Morphometric vertebral fractures of the lower thoracic and lumbar spine, physical function and quality of life in men. Osteoporos Int (2008) 0.90
Prevalence and risk factors of radiographic vertebral fracture in Brazilian community-dwelling elderly. Osteoporos Int (2010) 0.85
Semi-automatic determination of detailed vertebral shape from lumbar radiographs using active appearance models. Osteoporos Int (2011) 0.84
Agreement between semi-automatic radiographic morphometry and Genant semi-quantitative method in the assessment of vertebral fractures. Osteoporos Int (2011) 0.84
Detection of vertebral fractures in DXA VFA images using statistical models of appearance and a semi-automatic segmentation. Osteoporos Int (2010) 0.83
The broadening spectrum of osteoporotic vertebral fracture. Skeletal Radiol (2009) 0.80
Prediction models of prevalent radiographic vertebral fractures among older women. J Clin Densitom (2014) 0.79
Reconsideration of the relevance of mild wedge or short vertebral height deformities across a broad age distribution. Osteoporos Int (2014) 0.79
Imaging of vertebral fractures. Indian J Endocrinol Metab (2014) 0.77
Diagnosis of vertebral fractures in children: is a simplified algorithm-based qualitative technique reliable? Pediatr Radiol (2016) 0.77
Vertebral fractures and self-perceived health in elderly women and men in a population-based cross-sectional study: the Tromsø Study 2007-08. BMC Geriatr (2013) 0.76
The Prevalence of Undetected Vertebral Fracture in Patients with Back Pain by Dual-Energy X-ray Absorptiometry (DXA) of the Lateral Thoracic and Lumbar Spine. Asian Spine J (2011) 0.76
Differential diagnosis and management of an older runner with an atypical neurodynamic presentation: a case for clinical reasoning. Int J Sports Phys Ther (2015) 0.75
Reference values for vertebral shape in young Chinese women: implication for assessment of vertebral deformity. Eur Spine J (2010) 0.75
The FREEDOM trial: Is family medicine ready for biologic therapies? Can Fam Physician (2011) 0.75
Quantitative vertebral morphometry based on parametric modeling of vertebral bodies in 3D. Osteoporos Int (2012) 0.75
Imaging of diabetic bone. Endocrine (2017) 0.75
Vertebral fracture risk (VFR) score for fracture prediction in postmenopausal women. Osteoporos Int (2010) 0.75
The association between genetic variants of RUNX2, ADIPOQ and vertebral fracture in Korean postmenopausal women. J Bone Miner Metab (2014) 0.75
Prevalence and risk factors associated with low-impact fractures in men with rheumatoid arthritis. Clin Rheumatol (2013) 0.75
Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res (1993) 10.98
Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res (2000) 7.29
Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA (1990) 6.25
Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med (1991) 5.83
The radiological diagnosis of osteoporosis: a new approach. Clin Radiol (1960) 4.84
Population-based study of survival after osteoporotic fractures. Am J Epidemiol (1993) 4.71
Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. N Engl J Med (1982) 3.77
Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res (1999) 3.08
Contribution of vertebral deformities to chronic back pain and disability. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res (1992) 2.82
The assessment of vertebral deformity: a method for use in population studies and clinical trials. Osteoporos Int (1993) 2.66
Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res (2000) 2.55
Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone (2003) 2.51
Healing trabecular microfractures in the bodies of lumbar vertebrae. Ann Rheum Dis (1973) 2.50
Reduced pulmonary function in patients with spinal osteoporotic fractures. Osteoporos Int (1998) 2.45
The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int (2001) 2.32
Vertebral fractures predict subsequent fractures. Osteoporos Int (1999) 2.24
Comparison of methods for defining prevalent vertebral deformities: the Study of Osteoporotic Fractures. J Bone Miner Res (1995) 1.93
Classification of vertebral fractures. J Bone Miner Res (1991) 1.89
Recognition of vertebral fracture in a clinical setting. Osteoporos Int (2000) 1.87
Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women. Osteoporos Int (1993) 1.84
Quality of life issues in women with vertebral fractures due to osteoporosis. Arthritis Rheum (1993) 1.80
Excess mortality after hospitalisation for vertebral fracture. Osteoporos Int (2003) 1.76
Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study. Osteoporos Int (2003) 1.74
Vertebral fracture definition from population-based data: preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos). Osteoporos Int (2000) 1.72
Morphometric X-ray absorptiometry of the spine: correlation in vivo with morphometric radiography. Study of Osteoporotic Fractures Research Group. Osteoporos Int (1994) 1.70
Nuclear medicine studies in metabolic bone disease. Semin Musculoskelet Radiol (2002) 1.70
Consequences of vertebral deformities in older men and women. J Bone Miner Res (2000) 1.67
Number and type of vertebral deformities: epidemiological characteristics and relation to back pain and height loss. European Vertebral Osteoporosis Study Group. Osteoporos Int (1999) 1.59
Design of the Fracture Intervention Trial. Osteoporos Int (1993) 1.53
Vertebral deformities and functional impairment in men and women. J Bone Miner Res (1997) 1.53
Vertebral fractures in Beijing, China: the Beijing Osteoporosis Project. J Bone Miner Res (2000) 1.49
Comparison of methods for the visual identification of prevalent vertebral fracture in osteoporosis. Osteoporos Int (2004) 1.48
Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group. Arch Intern Med (2000) 1.47
The natural history of the osteoporotic vertebral fracture. Clin Rheumatol (1989) 1.44
Association between vertebral fracture and increased mortality in osteoporotic patients. J Bone Miner Res (2003) 1.39
Health impact associated with vertebral deformities: results from the European Vertebral Osteoporosis Study (EVOS). Osteoporos Int (1998) 1.38
Prevalence of vertebral fracture in women and the relationship with bone density and symptoms: the Chingford Study. J Bone Miner Res (1993) 1.38
Instant vertebral assessment: a noninvasive dual X-ray absorptiometry technique to avoid misclassification and clinical mismanagement of osteoporosis. J Clin Densitom (2001) 1.36
Assessment of prevalent and incident vertebral fractures in osteoporosis research. Osteoporos Int (2003) 1.33
Comparison of semiquantitative and quantitative techniques for the assessment of prevalent and incident vertebral fractures. Osteoporos Int (1995) 1.32
Visual assessment of vertebral deformity by X-ray absorptiometry: a highly predictive method to exclude vertebral deformity. Osteoporos Int (2000) 1.30
Assessing vertebral fractures. National Osteoporosis Foundation Working Group on Vertebral Fractures. J Bone Miner Res (1995) 1.30
Vertebral shape: automatic measurement with active shape models. Radiology (1999) 1.27
Measurement of anterior vertebral compressions and biconcave vertebrae. Am J Roentgenol Radium Ther Nucl Med (1968) 1.24
A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis. Osteoporos Int (1991) 1.23
Comparison of four morphometric definitions and a semiquantitative consensus reading for assessing prevalent vertebral fractures. Osteoporos Int (2001) 1.19
A case-control study of quality of life and functional impairment in women with long-standing vertebral osteoporotic fracture. Osteoporos Int (1999) 1.18
Clinical grading of spinal osteoporosis: quality of life components and spinal deformity in women with chronic low back pain and women with vertebral osteoporosis. J Bone Miner Res (1997) 1.13
Prevalent vertebral deformities: relationship to bone mineral density and spinal osteophytosis in elderly men and women. Osteoporos Int (1996) 1.08
A comparison of morphometric definitions of vertebral fracture. J Bone Miner Res (1991) 1.06
Morphometric X-ray absorptiometry and morphometric radiography of the spine: a comparison of prevalent vertebral deformity identification. J Bone Miner Res (2000) 1.06
Blinded reading of radiographs increases the frequency of errors in vertebral fracture detection. J Bone Miner Res (1996) 1.04
Epidemiology of vertebral osteoporosis. Bone (1992) 1.01
Case-control study of the pathogenesis and sequelae of symptomatic vertebral fractures in men. Osteoporos Int (1999) 1.01
Clinical utility of dual-energy vertebral assessment (DVA). Osteoporos Int (2003) 1.00
Recommendations for the registration of new chemical entities used in the prevention and treatment of osteoporosis. Calcif Tissue Int (1995) 0.97
Normal vertebral dimensions and normal variation in serial measurements of vertebrae. J Bone Miner Res (1989) 0.97
Identification of vertebral fractures in osteoporosis. Semin Musculoskelet Radiol (2002) 0.96
Vertebral morphometry: normative data. Bone Miner (1988) 0.94
A newly developed spine deformity index (SDI) to quantitate vertebral crush fractures in patients with osteoporosis. Bone Miner (1988) 0.93
Aging of the thoracic spine: distinction between wedging in osteoarthritis and fracture in osteoporosis--a cross-sectional and longitudinal study. Bone (1994) 0.93
Measurements of vertebral shape by radiographic morphometry: sex differences and relationships with vertebral level and lumbar lordosis. Skeletal Radiol (1998) 0.93
Visual identification of vertebral fractures in osteoporosis using morphometric X-ray absorptiometry. J Bone Miner Res (2003) 0.92
Semiquantitative evaluation of prevalent vertebral deformities in men and their relationship with osteoporosis: the MINOS study. Osteoporos Int (2001) 0.90
Vertebral deformity, bone mineral density, back pain and height loss in unscreened women over 50 years. Osteoporos Int (1993) 0.90
Vertebral morphometry studies using dual-energy x-ray absorptiometry. Semin Nucl Med (1997) 0.89
Diffusion-weighted imaging of bone marrow: current status. Eur Radiol (2003) 0.88
Vertebral morphometry: a comparison of long-term precision of morphometric X-ray absorptiometry and morphometric radiography in normal and osteoporotic subjects. Osteoporos Int (2001) 0.87
Prevalence of vertebral compression fracture deformity by X-ray absorptiometry of lateral thoracic and lumbar spines in a population referred for bone densitometry. J Clin Densitom (2002) 0.86
Vertebral deformity in men. J Bone Miner Res (1992) 0.86
Identification of vertebral deformities in women: comparison of radiological assessment and quantitative morphometry using morphometric radiography and morphometric X-ray absorptiometry. J Bone Miner Res (2000) 0.86
Effects of raloxifene on fracture severity in postmenopausal women with osteoporosis: results from the MORE study. Multiple Outcomes of Raloxifene Evaluation. Osteoporos Int (2002) 0.85
What is a vertebral fracture? Bone (1996) 0.85
Variation in vertebral height ratios in population studies. European Vertebral Osteoporosis Study Group. J Bone Miner Res (1994) 0.85
Vertebral fractures. BMJ (1992) 0.84
Sex difference in the validity of vertebral deformities as an index of prevalent vertebral osteoporotic fractures: a population survey of older men and women. Osteoporos Int (2000) 0.84
Vertebral morphometry in diagnosis of spinal fractures. Bone Miner (1988) 0.84
A new method for vertebral fracture diagnosis. J Bone Miner Res (1993) 0.83
Measurement imprecision in vertebral morphometry of spinal radiographs obtained in the European Prospective Osteoporosis Study: consequences for the identification of prevalent and incident deformities. Br J Radiol (1999) 0.83
Secondary osteoporosis and the risk of vertebral deformities in women. Bone (1999) 0.83
Thoracic spine compression fractures in Finland. Clin Orthop Relat Res (1986) 0.83
Age-related changes in vertebral height ratios and vertebral fracture. Osteoporos Int (1997) 0.83
A simple X-ray method for monitoring progress of osteoporosis. Lancet (1981) 0.82
Influence of fracture criteria on the outcome of a randomized trial of therapy. Osteoporos Int (1998) 0.81
Vertebral fracture or vertebral deformity. Calcif Tissue Int (1992) 0.81
The natural history of kyphosis in postmenopausal women. Bone (1995) 0.81
The index of radiographic area (IRA): a new approach to estimating the severity of vertebral deformity. Bone Miner (1991) 0.80
Radiology of osteoporosis. Semin Musculoskelet Radiol (2002) 0.79
Spine deformity index (SDI) versus other objective procedures of vertebral fracture identification in patients with osteoporosis: a comparative study. J Bone Miner Res (1991) 0.78
Precision in assessment of osteoporosis from spine radiographs. Eur J Radiol (1991) 0.78
Comparison of morphometric assessment of prevalent vertebral deformities in women using different reference data. Bone (2000) 0.78
Reversal of vertebral deformities in osteoporosis: measurement error or "rebound"? J Bone Miner Res (1994) 0.78
Reference data of vertebral morphometry by X-ray absorptiometry (MXA) in Argentine women. Calcif Tissue Int (2000) 0.78
Radiological osteoporosis: correlation with dietary and biochemical findings. J Am Geriatr Soc (1971) 0.78
Vertebral measurements for assessment of osteoporosis. Br J Radiol (1994) 0.77
Identification of vertebral deformities in men: comparison of morphometric radiography and morphometric X-ray absorptiometry. Osteoporos Int (1999) 0.77
Clinical evaluation of spine morphometric X-ray absorptiometry. Br J Rheumatol (1998) 0.76
Vertebral wedge angle measured by morphometric X-ray absorptiometry. Osteoporos Int (2001) 0.76
Validity in diagnosing osteoporosis. Observer variation in interpreting spinal radiographs. Eur J Radiol (1984) 0.76
Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med (2001) 9.57
Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet (1993) 8.39
The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res (2001) 6.93
PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol (1997) 5.76
Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. Science (1990) 5.49
Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int (2000) 4.85
A novel human opsin in the inner retina. J Neurosci (2000) 4.30
Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer (2003) 4.14
Estimation of the number of sex alleles and queen matings from diploid male frequencies in a population of Apis mellifera. Genetics (1977) 3.98
Melanopsin: An opsin in melanophores, brain, and eye. Proc Natl Acad Sci U S A (1998) 3.85
The learning curve for laparoscopic colorectal surgery. Preliminary results from a prospective analysis of 1194 laparoscopic-assisted colectomies. Arch Surg (1997) 3.57
Effect of screening on cervical cancer mortality in England and Wales: analysis of trends with an age period cohort model. BMJ (1999) 3.50
A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma. Br J Haematol (2004) 3.49
Evolution of Escherichia coli during growth in a constant environment. Genetics (1987) 3.44
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int (2010) 3.36
NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci U S A (1990) 3.28
Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat Genet (1999) 3.24
Microbial evolution in a simple unstructured environment: genetic differentiation in Escherichia coli. Genetics (1994) 3.19
Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2002) 3.16
Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed) (1986) 3.14
Coronary vasospasm induced by subcutaneous sumatriptan. BMJ (1992) 3.13
Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study. Osteoporos Int (2012) 3.13
RNA recognition by a Staufen double-stranded RNA-binding domain. EMBO J (2000) 3.12
Frequency of fixation of adaptive mutations is higher in evolving diploid than haploid yeast populations. Nature (1983) 3.03
Milk intake and bone mineral acquisition in adolescent girls: randomised, controlled intervention trial. BMJ (1997) 3.01
Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest (2000) 2.94
Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ (2001) 2.85
Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun (1990) 2.77
Repeated evolution of an acetate-crossfeeding polymorphism in long-term populations of Escherichia coli. Mol Biol Evol (1998) 2.69
Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. Clin Cancer Res (2001) 2.65
Polycystic ovaries--a common finding in normal women. Lancet (1988) 2.58
A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site. Biochemistry (1991) 2.57
Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med (1989) 2.56
Evidence for high-energy extraterrestrial neutrinos at the IceCube detector. Science (2013) 2.56
Determinants of patient satisfaction and willingness to return with emergency care. Ann Emerg Med (2000) 2.49
Admixture studies and the detection of selection. Science (1973) 2.41
Relative fitness can decrease in evolving asexual populations of S. cerevisiae. Nature (2006) 2.40
Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res (1990) 2.39
Arm edema in breast cancer patients. J Natl Cancer Inst (2001) 2.35
ABC of rheumatology. Osteoporosis. BMJ (1995) 2.33
A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess (1999) 2.32
Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ (1988) 2.29
Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev (2007) 2.26
Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol Cell Biol (2001) 2.24
Kit/stem cell factor receptor-induced activation of phosphatidylinositol 3'-kinase is essential for male fertility. Nat Genet (2000) 2.18
Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition. Cancer Res (2001) 2.18
Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet (1986) 2.14
The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation. Osteoporos Int (2000) 2.14
Case-mix adjustment of the National CAHPS benchmarking data 1.0: a violation of model assumptions? Health Serv Res (2001) 2.10
Screening for vertebral osteoporosis using individual risk factors. The Multicentre Vertebral Fracture Study Group. Osteoporos Int (1991) 2.07
Fas ligand, Bcl-2, granulocyte colony-stimulating factor, and p38 mitogen-activated protein kinase: Regulators of distinct cell death and survival pathways in granulocytes. J Exp Med (2000) 2.07
Frequency-Dependent Selection for Plasmid-Containing Cells of ESCHERICHIA COLI. Genetics (1979) 2.07
Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet (2001) 2.05
Proteasome inhibition measurements: clinical application. Clin Chem (2000) 2.04
First observation of PeV-energy neutrinos with IceCube. Phys Rev Lett (2013) 2.00
Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynaecol (1985) 2.00
Estimation of phylogenetic relationships from DNA restriction patterns and selection of endonuclease cleavage sites. Proc Natl Acad Sci U S A (1982) 1.98
Genetic evidence that Neisseria gonorrhoeae produces specific receptors for transferrin and lactoferrin. J Bacteriol (1990) 1.94
The proteasome inhibitor PS-341 in cancer therapy. Clin Cancer Res (1999) 1.94
Characterization of the binding site for nevirapine (BI-RG-587), a nonnucleoside inhibitor of human immunodeficiency virus type-1 reverse transcriptase. J Biol Chem (1991) 1.90
Distinct roles of two conserved Staufen domains in oskar mRNA localization and translation. EMBO J (2000) 1.87
Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability. J Bone Miner Res (1998) 1.85
The maintenance of Plasmid-containing organisms in populations of Escherichia coli. J Gen Microbiol (1981) 1.85
Growth in infancy and bone mass in later life. Ann Rheum Dis (1997) 1.84
Treatment failure in osteoporosis. Osteoporos Int (2012) 1.82
Intrauterine programming of adult body composition. J Clin Endocrinol Metab (2001) 1.76
Laparoscopic complications in markedly obese urologic patients (a multi-institutional review) Urology (1996) 1.75
Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia. Diabetologia (2006) 1.74
Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis (1995) 1.73
Prevalence and incidence of vertebral deformities. Osteoporos Int (1993) 1.72
Health-related quality of life and radiographic vertebral fracture. Osteoporos Int (2003) 1.70
Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab (1996) 1.69
Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis. Proc Natl Acad Sci U S A (1998) 1.69
Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB. Int J Radiat Oncol Biol Phys (2001) 1.67
Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis for end-stage renal disease. Cochrane Database Syst Rev (2007) 1.67
Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice. Oncogene (2009) 1.66
Fibromyalgia: a risk factor for osteoporosis. J Rheumatol (1999) 1.63
Nonoperative management of posterior tibial tendon dysfunction. Foot Ankle Int (1996) 1.61
One year prospective open study of the effect of high dose inhaled steroids, fluticasone propionate, and budesonide on bone markers and bone mineral density. Thorax (1999) 1.60
Evaluation of outpatient geriatric assessment: a randomized multi-site trial. J Am Geriatr Soc (1995) 1.58
Reduction in the risk of clinical fractures after a single dose of zoledronic Acid 5 milligrams. J Clin Endocrinol Metab (2013) 1.57
Molecular and imaging correlates of the fragile X-associated tremor/ataxia syndrome. Neurology (2006) 1.55
Cysteine usage increases the need for acetate in neonates who receive total parenteral nutrition. Am J Clin Nutr (1991) 1.53
Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency-associated transcript RNA in latently infected cells of the rat brain. J Virol (1994) 1.51
Device-specific thresholds to diagnose osteoporosis at the proximal femur: an approach to interpreting peripheral bone measurements in clinical practice. Osteoporos Int (2006) 1.51
Histomorphometric and biochemical characterization of bone following acute severe burns in children. Bone (1995) 1.51
Proteasome inhibition with bortezomib (PS-341): a phase I study with pharmacodynamic end points using a day 1 and day 4 schedule in a 14-day cycle. J Clin Oncol (2005) 1.50
Measurement of osteocalcin. Ann Clin Biochem (2000) 1.49
Comparison of methods for the visual identification of prevalent vertebral fracture in osteoporosis. Osteoporos Int (2004) 1.48
Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models. J Pharmacol Exp Ther (1998) 1.46
A community-level HIV prevention intervention for inner-city women: results of the women and infants demonstration projects. Am J Public Health (2000) 1.46
Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (2003) 1.45
Galectin-1 prolongs survival of mouse liver allografts from Flt3L-pretreated donors. Am J Transplant (2013) 1.44
Ultrasound demonstration of increased frequency of functional ovarian cysts in women using progestogen-only oral contraception. Br J Obstet Gynaecol (1985) 1.44
Comparison of rates of bone loss from the spine measured using two manufacturers' densitometers. J Bone Miner Res (1995) 1.42
Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. J Clin Endocrinol Metab (2006) 1.41
Effect of feeding on bone turnover markers and its impact on biological variability of measurements. Bone (2002) 1.40
Juvenile spring eruption of the ears: a probable variant of polymorphic light eruption. Br J Dermatol (1991) 1.40
Wnt pathway regulation in chronic renal allograft damage. Am J Transplant (2009) 1.39
The Wake-up Call. West J Med (1993) 1.39